Records containing: Hepatocellular Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-06-26The Efficacy and Safety of HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma: an Open, Single Arm Exploratory Study
-
CLINICAL_TRIALS study record update · 2024-06-25The Role of Non-contrast Abbreviated MRI for Secondary Surveillance of Hepatocellular Carcinoma After Curative Treatment: a Prospective Multicenter Study
-
CLINICAL_TRIALS study record update · 2024-06-25CAR-T Cell Targeting GPC3 for Immunotherapy of Hepatocellular Carcinoma: Phase I Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-06-25Trametinib Combined With Everolimus and Lenvatinib in the Treatment of Recurrent/Refractory Advanced Solid Tumors: a Phase II Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-06-25TACE Combined With Sorafenib and PD-1 mAb in the Treatment of BCLC B/C Hepatocellular Carcinoma: Single Arm, Single Center, Open Label Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-06-20Cohort Study of Patients With Primary Hepatocellular Carcinoma or Cholangiocarcinoma
-
CLINICAL_TRIALS study record update · 2024-06-17Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: a Randomized, Open-label, Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-06-14Collection of Blood to Evaluate Epigenomics and Protein Biomarkers for the Detection of Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2024-06-12Clinical Outcomes and Quality of Life After Transarterial Radioembolization With Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
-
CLINICAL_TRIALS study record update · 2024-06-10Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2024-06-05A Randomized Phase II Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)
-
CLINICAL_TRIALS study record update · 2024-06-04Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease: A Multicenter, Randomized, Double-blind, Placebo Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-06-04Liver Cancer Disparities in American Indian and Alaska Native Persons
-
CLINICAL_TRIALS study record update · 2024-05-30An Open-Label Multi-Center Phase Ib/II Study of the Combination of AK105 and Anlotinib Hydrochloride in the First-Line Treatment of Patients With Unresectable Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2024-05-30Lenvatinib Versus Bevacizumab Combined With Immune Checkpoint Inhibitors and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Retrospective, Multi-center, and Propensity Score Matching Study
-
CLINICAL_TRIALS study record update · 2024-05-29Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients Based on "Guideline for Re-examination of New Drugs"
-
CLINICAL_TRIALS study record update · 2024-05-29A Randomized, Open-label, Phase 3 Trial Evaluating Adjuvant Transarterial Chemoembolization for TNM Stage I and II Hepatocellular Carcinoma Recurrence After Curative Resection
-
CLINICAL_TRIALS study record update · 2024-05-22Phase II Trial of cTACE Plus Sintilimab for Treatment of Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria
-
CLINICAL_TRIALS study record update · 2024-05-22ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery of HCC Patients
-
CLINICAL_TRIALS study record update · 2024-05-21An Intraoperative Guidance Platform for Radio Frequency Ablation
-
CLINICAL_TRIALS study record update · 2024-05-21A Retrospective Study Comparing Interventional Therapy (TACE/HAIC) Combined With PD-1/PD-L1 Inhibitors and Anti-angiogenic Agents Versus PD-1/PD-L1 Inhibitors and Anti-angiogenic Agents Alone in the First-line Treatment of Intermediate and Advanced Hepatocellular Carcinoma Beyond up to Seven
-
CLINICAL_TRIALS study record update · 2024-05-20The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in China
-
CLINICAL_TRIALS study record update · 2024-05-17Vienna Hypothermic Oxygenated Machine Perfusion for Liver Transplantation Study
-
CLINICAL_TRIALS study record update · 2024-05-16Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2024-05-16The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial